Concurrent Investment Advisors LLC Acquires 107 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Concurrent Investment Advisors LLC boosted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 15.5% in the second quarter, Holdings Channel reports. The firm owned 796 shares of the biotechnology company’s stock after purchasing an additional 107 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Axon Enterprise were worth $234,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Truist Financial Corp increased its holdings in shares of Axon Enterprise by 4.0% during the fourth quarter. Truist Financial Corp now owns 3,991 shares of the biotechnology company’s stock worth $1,031,000 after buying an additional 153 shares in the last quarter. Natixis Advisors L.P. increased its holdings in shares of Axon Enterprise by 16.3% during the fourth quarter. Natixis Advisors L.P. now owns 24,792 shares of the biotechnology company’s stock worth $6,404,000 after buying an additional 3,468 shares in the last quarter. 9258 Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $204,000. M&T Bank Corp increased its holdings in shares of Axon Enterprise by 18.4% during the fourth quarter. M&T Bank Corp now owns 3,437 shares of the biotechnology company’s stock worth $887,000 after buying an additional 535 shares in the last quarter. Finally, Spire Wealth Management increased its holdings in shares of Axon Enterprise by 10,120.6% during the fourth quarter. Spire Wealth Management now owns 3,475 shares of the biotechnology company’s stock worth $892,000 after buying an additional 3,441 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on AXON. Jefferies Financial Group began coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price objective for the company. Craig Hallum raised their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Robert W. Baird raised their price target on shares of Axon Enterprise from $355.00 to $360.00 and gave the company an “outperform” rating in a report on Wednesday, August 7th. Bank of America assumed coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price target for the company. Finally, Needham & Company LLC reissued a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a report on Wednesday, August 7th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $358.08.

Read Our Latest Stock Report on Axon Enterprise

Insider Transactions at Axon Enterprise

In other news, Director Matthew R. Mcbrady sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the transaction, the director now directly owns 4,892 shares of the company’s stock, valued at $1,783,916.72. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Matthew R. Mcbrady sold 2,000 shares of the business’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the sale, the director now directly owns 4,892 shares in the company, valued at $1,783,916.72. The disclosure for this sale can be found here. Insiders have sold a total of 277,750 shares of company stock valued at $101,046,568 over the last three months. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

AXON opened at $355.35 on Thursday. The company has a fifty day moving average price of $329.07 and a two-hundred day moving average price of $309.94. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. Axon Enterprise, Inc. has a 52 week low of $189.12 and a 52 week high of $378.89. The firm has a market capitalization of $26.82 billion, a PE ratio of 103.90, a P/E/G ratio of 9.78 and a beta of 0.95.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The firm had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business’s quarterly revenue was up 34.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.80 EPS. As a group, analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.